Larvol Delta - Revisiting-cytomegalovirus-in-pediatric-allogeneic-hematopoietic-stem-cell-transplant-recipients-current-strategies-for-prevention-and-management-in-the-letermovir-era

Prevymis (letermovir) - Merck (MSD)

Livtencity (maribavir) - Takeda, GSK

http://www.ncbi.nlm.nih.gov/pubmed/41018055

Diego R Hijano; Lisa Hiskey; Ramia Zakhour

Sep 29, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next